Novartis grows strongly in the final quarter
Published: Wednesday, Jan 31st 2024, 07:20
Retour au fil d'actualité
Novartis increased sales by 8 percent to 11.4 billion US dollars in the fourth quarter of 2023 and achieved a higher profit. The dividend is to be increased by 10 centimes to 3.30 Swiss francs per share, as the pharmaceutical company announced on Wednesday.
©Keystone/SDA